UH-OH LABS INC

UH-OH LABS INC specializes in the design, development, and deployment of advanced analytical laboratory instrumentation, with a demonstrated focus on molecular diagnostic platforms for infectious disease detection. The company’s technical expertise centers on loop-mediated isothermal amplification (LAMP) assay technology, particularly the SARS-CoV-2 Loop-de-Loop™ platform, engineered for high-throughput screening and point-of-care deployment. Their work integrates microfluidics, nucleic acid amplification, and rapid readout systems to enable sensitive, specific, and field-deployable diagnostics, positioning them at the intersection of clinical diagnostics and instrumentation engineering. Key differentiators include rapid assay development cycles, optimization for low-resource settings, and integration of automation-ready workflows suitable for public health emergency response. The contractor has delivered solutions to the Department of Health and Human Services, primarily supporting public health surveillance and emergency preparedness initiatives through diagnostic instrument development. This relationship reflects a targeted engagement in biodefense and pandemic response, where rapid deployment of validated diagnostic tools is critical. The nature of the work suggests a partnership model focused on translating laboratory prototypes into scalable, regulatory-compliant medical devices for federal health operations. UH-OH LABS INC operates primarily within NAICS 334516, which encompasses the manufacturing of analytical laboratory instruments, particularly those used in molecular diagnostics and clinical testing. Their market positioning is niche but critical—specializing in next-generation nucleic acid detection systems that bridge the gap between research-grade tools and field-deployable diagnostics. This vertical specialization aligns with growing demand for decentralized, rapid-response testing infrastructure in public health and clinical laboratories. As a small business structured as a 2L entity based in Santa Clara, California, UH-OH LABS INC operates without federal certifications but leverages its geographic proximity to Silicon Valley’s biotech and engineering ecosystems to drive innovation. The company’s footprint is focused on federal health and biomedical contracting, with an emphasis on technical agility and rapid prototyping in high-stakes diagnostic environments.